Patents Assigned to NANJING RUIJIE PHARMATECH CO., LTD.
  • Compounds and their uses as ACC inhibitors
    Patent number: 10995099
    Abstract: The present invention provides compounds of Formula (I) which can be used as ACC inhibitors and potently as therapeutic agents against diseases mediated by ACC.
    Type: Grant
    Filed: July 17, 2018
    Date of Patent: May 4, 2021
    Assignee: Nanjing Ruijie Pharmatech Co., Ltd.
    Inventors: Junbo Zhang, Hong Liao, Peipei Wang, Peng Wang
  • NOVEL COMPOUNDS AND THEIR USES AS ACC INHIBITORS
    Publication number: 20200140454
    Abstract: The present invention provides compounds of Formula (I) which can be used as ACC inhibitors and potently as therapeutic agents against diseases mediated by ACC.
    Type: Application
    Filed: July 17, 2018
    Publication date: May 7, 2020
    Applicant: NANJING RUIJIE PHARMATECH CO., LTD.
    Inventors: Junbo Zhang, Hong Liao, Peipei Wang, Peng Wang